Related Experiment Videos
p73-mediated chemosensitivity: a preferential target of oncogenic mutant p53
Sabrina Strano1, Giovanni Blandino
1Department of Experimental Oncology, Regina Elena Cancer Institute, 00158-Rome, Italy.
Cell Cycle (Georgetown, Tex.)
|July 10, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer.
Molecular oncology·2026
Upregulation of ITM2A by p53 activation modulates p53 function through physical interaction.
Cell cycle (Georgetown, Tex.)·2026
The hormetic landscape: from evolutionary origination to mechanistic pathways in therapeutics.
Cell cycle (Georgetown, Tex.)·2026
The effect of energy metabolism on embryonic development and endometrial receptivity in patients with repeated implantation failure.
Cell cycle (Georgetown, Tex.)·2026
The role of IL-37 in inflammatory bowel disease and colitis-associated colorectal cancer.
Cell cycle (Georgetown, Tex.)·2026
Exploratory multi-omics links CCL2/TIMP1 axis to immunosuppressive TME in glioblastoma.
Cell cycle (Georgetown, Tex.)·2026
Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study.
Journal of visualized experiments : JoVE·2026
An Engineering-Editable Hybrid Membrane‑Camouflaged DNA Origami Drug Enables Checkpoint Blockade and Immune Activation for Triple-Negative Breast Cancer Immunotherapy.
Angewandte Chemie (International ed. in English)·2026
Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Restoration of m6A-Modified circPSMB1 Suppresses Chordoma Progression and Enables Local Nanotherapeutic Intervention.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026